April 21, 2020 / Leah Rosenbaum, Forbes Staff TOPLINE In a small randomized control study, researchers in China found that HIV drug Kaletra and influenza drug Arbidol have no effect on patients with mild to moderately severe COVID-19 infections. KEY FACTS The trial, published by the journal Med by Cell Press, included 86 patients: 34 …